Nathalie Cheron

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

François Guilhot, Claude Chastang, Mauricette Michallet et al. · New England Journal of Medicine · 1997 · 553 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

N Smadja, C Fruchart, F Isnard et al. · Leukemia · 1998 · 169 citations

Life Sciences, Hematology, Oncology +17

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease

Christophe Fermé, Y Bastion, Éric Lepage et al. · Annals of Oncology · 1995 · 124 citations · Full text

Medicine, Oncology, Chemotherapy +11

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase

Martine Gardembas, Philippe Rousselot, Michel Tulliez et al. · Blood · 2003 · 61 citations · Full text

Medicine, Oncology, Pharmacology +12

Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.

L Fouillard, J.P. Laporte, Myriam Labopin et al. · Journal of Clinical Oncology · 1998 · 53 citations

Medicine, Hematology, Oncology +16